Reciprocal relationship from JNJ graph: Reciprocal relationship from BNR graph: days (1) For the year ended December 31, 2024. The design and performance of OncoScreen ™ Plus and OncoCompass ™ Plus h…
days (1) For the year ended December 31, 2024. The design and performance of OncoScreen ™ Plus and OncoCompass ™ Plus has been endorsed by their adoption in over 20 clinical trials and studies. For e…
days (1) For the year ended December 31, 2024. The design and performance of OncoScreen ™ Plus and OncoCompass ™ Plus has been endorsed by their adoption in over 20 clinical trials and studies. For e…
Reciprocal relationship from MYGN graph: Reciprocal relationship from BNR graph: Reciprocal relationship from MYGN graph: Reciprocal relationship from BNR graph: days (1) For the year ended December …
Burning Rock Biotech Limited Debt Obligations
Instrument
Description
Confidence
Evidence
BNR-DEBT-8308
Warrants outstanding: 0
90%
xbrl warrant detail from xbrl 2022-12-31.
BNR-DEBT-8309
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2020-12-31.
BNR-DEBT
Debt stack $6.3M
90%
Market cache reports total debt of $6.3M.
Burning Rock Biotech Limited Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Burning Rock Biotech Limited.
Burning Rock Biotech Limited Ownership
Holder
Name
Confidence
Evidence
BNR-OWNER-BARCLAYS-PLC
BARCLAYS PLC
90%
13F overlay lists BARCLAYS PLC as top holder; 1 tracked holders.
Burning Rock Biotech Limited Extended Supply Chain Network